(VIANEWS) - Tyler Technologies (TYL), Afya (AFYA), Glacier Bancorp (GBCI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Tyler Technologies (TYL)
50.2% sales growth and 9.76% return on equity
Tyler Technologies, Inc. provides integrated information management solutions and services for the public sector in the United States and internationally.
Tyler Technologies's sales growth this year is expected to be 38.8% and 18.1% for next year.
Year-on-year quarterly revenue growth grew by 6.6%, now sitting on 1.13B for the twelve trailing months.
Volume
Today's last reported volume for Tyler Technologies is 338019 which is 78.63% above its average volume of 189227.
Tyler Technologies's sales growth is a negative 0% for the current quarter and 50.2% for the next. The company's growth estimates for the current quarter and the next is 18% and 25.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.76%.
Volatility
Tyler Technologies's last day, last week, and last month's current intraday variation average was 4.22%, 5.84%, and 2.65%, respectively.
Tyler Technologies's highest amplitude of average volatility was 4.90% (day), 4.40% (last week), and 3.29% (last month), respectively.
Tyler Technologies's Stock Yearly Top and Bottom Value
Tyler Technologies's stock is valued at $411.28 at 19:22 EST, way below its 52-week high of $549.08 and way higher than its 52-week low of $372.80.
Tyler Technologies's Moving Average
Tyler Technologies's value is way under its 50-day moving average of $501.58 and way below its 200-day moving average of $464.56.2. Afya (AFYA)
20.6% sales growth and 9.71% return on equity
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil.
Afya's sales growth this year is anticipated to be 30.7% and 24.9% for next year.
Year-on-year quarterly revenue growth grew by 35.8%, now sitting on 1.42B for the twelve trailing months.
Volume
Today's last reported volume for Afya is 184383 which is 46.11% below its average volume of 342154.
Afya's sales growth for the next quarter is 20.6%. The company's growth estimates for the ongoing quarter and the next is 20% and 33.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.71%.
Volatility
Afya's last day, last week, and last month's current intraday variation average was 1.91%, 2.04%, and 2.08%, respectively.
Afya's highest amplitude of average volatility was 3.64% (day), 4.31% (last week), and 3.67% (last month), respectively.
Afya's Stock Yearly Top and Bottom Value
Afya's stock is valued at $13.64 at 19:22 EST, way under its 52-week high of $28.23 and above its 52-week low of $12.62.
Afya's Moving Average
Afya's worth is way under its 50-day moving average of $16.50 and way under its 200-day moving average of $21.18.3. Glacier Bancorp (GBCI)
19.8% sales growth and 10.38% return on equity
Glacier Bancorp, Inc. operates as the bank holding company for Glacier Bank that provides commercial banking services to individuals, small to medium-sized businesses, community organizations, and public entities in the United States.
Glacier Bancorp's sales growth this year is anticipated to be 14.7% and 10.1% for next year.
Year-on-year quarterly revenue growth declined by 4.7%, now sitting on 784.26M for the twelve trailing months.
Volume
Today's last reported volume for Glacier Bancorp is 263593 which is 24.81% below its average volume of 350596.
Glacier Bancorp's sales growth for the next quarter is 19.8%. The company's growth estimates for the ongoing quarter and the next is a negative 28.2% and negative -17.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.38%.
Volatility
Glacier Bancorp's last day, last week, and last month's current intraday variation average was 0.21%, 1.22%, and 1.53%, respectively.
Glacier Bancorp's highest amplitude of average volatility was 2.16% (day), 2.46% (last week), and 3.81% (last month), respectively.
Glacier Bancorp's Stock Yearly Top and Bottom Value
Glacier Bancorp's stock is valued at $52.29 at 19:22 EST, way below its 52-week high of $67.35 and higher than its 52-week low of $48.62.
Glacier Bancorp's Moving Average
Glacier Bancorp's worth is below its 50-day moving average of $55.83 and under its 200-day moving average of $55.50.4. IDEXX Laboratories (IDXX)
10.1% sales growth and 126.53% return on equity
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide.
IDEXX Laboratories's sales growth this year is expected to be 18.1% and 11% for next year.
Year-on-year quarterly revenue growth grew by 12.3%, now sitting on 3.14B for the twelve trailing months.
Volume
Today's last reported volume for IDEXX Laboratories is 497354 which is 4.27% above its average volume of 476975.
IDEXX Laboratories's sales growth for the next quarter is 10.1%. The company's growth estimates for the ongoing quarter and the next is 11.8% and negative -10%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 126.53%.
Volatility
IDEXX Laboratories's last day, last week, and last month's current intraday variation average was 0.80%, 1.45%, and 2.15%, respectively.
IDEXX Laboratories's highest amplitude of average volatility was 2.24% (day), 3.03% (last week), and 3.96% (last month), respectively.
IDEXX Laboratories's Stock Yearly Top and Bottom Value
IDEXX Laboratories's stock is valued at $489.45 at 19:22 EST, way under its 52-week high of $706.95 and higher than its 52-week low of $453.80.
IDEXX Laboratories's Moving Average
IDEXX Laboratories's worth is way below its 50-day moving average of $626.87 and way under its 200-day moving average of $602.47.5. ServisFirst Bancshares (SFBS)
6% sales growth and 19.86% return on equity
ServisFirst Bancshares, Inc. operates as the bank holding company for ServisFirst Bank that provides various banking services to individual and corporate customers.
ServisFirst Bancshares's sales growth this year is anticipated to be 13.1% and 5.7% for next year.
Year-on-year quarterly revenue growth grew by 21.5%, now sitting on 380.06M for the twelve trailing months.
Volume
Today's last reported volume for ServisFirst Bancshares is 176886 which is 1.37% above its average volume of 174479.
ServisFirst Bancshares's sales growth for the next quarter is 6%. The company's growth estimates for the current quarter and the next is 4.3% and 3.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.86%.
Volatility
ServisFirst Bancshares's last day, last week, and last month's current intraday variation average was 0.41%, 1.58%, and 1.28%, respectively.
ServisFirst Bancshares's highest amplitude of average volatility was 3.05% (day), 2.75% (last week), and 3.10% (last month), respectively.
ServisFirst Bancshares's Stock Yearly Top and Bottom Value
ServisFirst Bancshares's stock is valued at $85.06 at 19:22 EST, below its 52-week high of $89.35 and way above its 52-week low of $45.13.